Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trialḰazunori Toyoda, Naoko Kumagai, Kazumi Kimura et al.|The Lancet Neurology|2019Cited by 216
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral AnticoagulantsThomas R. Meinel, Madlaine Mueller, Duncan Wilson et al.|JAMA Neurology|2023Cited by 119